<DOC>
	<DOCNO>NCT00189176</DOCNO>
	<brief_summary>This study evaluate safety administration copper chelate agent , tetrathiomolybdate , patient idiopathic pulmonary fibrosis fail previous treatment . The primary endpoint study safety secondary endpoint include change pulmonary function , exercise capacity , quality life .</brief_summary>
	<brief_title>Safety Study Tetrathiomolybdate Patients With Idiopathic Pulmonary Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Tetrathiomolybdate</mesh_term>
	<mesh_term>Molybdenum</mesh_term>
	<criteria>Diagnosis idiopathic pulmonary fibrosis Disease progression despite six month treatment ( steroid with/without azathioprine cyclophosphamide ) define least one following : Increased symptom Decline force vital capacity least 10 % Decline diffusion capacity carbon monoxide least 20 % Increased infiltrate CXR high resolution CT scan Taking &lt; 15 mg prednisone least 30 day prior screen Age 3580 , inclusive Able understand write informed consent comply study protocol Significant environmental exposure Diagnosis collagen vascular disease Evidence active infection Clinically significant cardiac disease : Myocardial infarction , coronary artery bypass angioplasty within 6mo Unstable angina pectoris Congestive heart failure require hospitalization within 6 month Uncontrolled arrhythmia Poorly control severe diabetes mellitus Pregnancy lactation Women childbearing potential use medically approve mean contraception ( i.e . oral contraceptive , intrauterine device , diaphragm , Norplant ) Current enrollment another experimental protocol Physiologic Criteria : FEV1/FVC &lt; 0.60 Laboratory Criteria : Total bilirubin &gt; 1.5 X upper limit normal AST ALT &gt; 3X upper limit normal Alkaline phosphatase &gt; 3X upper limit normal White blood cell count &lt; 2,500/mm3 Hematocrit &lt; 30 % Platelets &lt; 100,000/mm3 Prothrombin time INR &gt; 1.5</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>